Tuesday, March 22, 2022

Evoq Remedies IPO Subscription Status Today Live Update from BSE

Evoq Remedies IPO subscription status is to start from March 17, 2022, Thursday. The IPO is been subscribed by NII and Retail investors. Evoq Remedies is a BSE SME IPO and they are going to raise ₹9.72 crores via SME IPO. The company was incorporated in 2010 based in Ahmedabad. The company is doing marketing, trading and distribution of pharmaceutical formulation products. The product range includes anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants, and injections. The company reported ₹10.02 crores of revenues in 2021 against ₹9.07 crores in 2020. The company's financial report looks fine while profit is growing year on year but still on a lower side. Please check the Evoq Remedies IPO subscription status details over here.

IPOWatch View
We recommend investors may apply for an IPO with risk (Avoid). Investors should also look at the Retail and HNI numbers before investing. You can check the Evoq Remedies IPO allotment status here.
Evoq Remedies

    Evoq Remedies IPO Subscription Status (Live Update - Day 3)

    Category Day 1 Day 2 Day 3
    NII 0.11 0.27 0.30
    RII 0.26 1.12 3.03
    Total 0.19 0.70 1.67

    Evoq Remedies IPO Investor Categories

    • Non-Institutional Investors(NII): Individual Investors, NRIs, Companies, Trusts, etc
    • Retail Individual Investors (RII): Retail Individual Investors or NRIs

    Evoq Remedies IPO Date & Price Band

     IPO Open:  17 March 2022
     IPO Close:  22 March 2022
     IPO Size:  Approx ₹9.72 Crores
     Face Value:  ₹10 Per Equity Share
     Price Band:  ₹27 Per Equity Share
     Listing on:  BSE SME
     Retail Quota:  50%
     NII Quota:  50%
     DRHP Draft Prospectus:  Click Here
     RHP Draft Prospectus:  Click Here

    Evoq Remedies IPO Market Lot

    The Evoq Remedies IPO minimum market lot is 4000 shares with ₹108,000 application amount.
     IPO Lot Size:  Minimum 4000 Shares for 1 lot
     Minimum Amount:  ₹108,000 for 1 lot

    Evoq Remedies IPO Time Table, Allotment & Listing

    The Evoq Remedies IPO date is 17 March 2022 and the IPO close date is 22 March 2022. The allotment date is 25 March 2022 and the IPO may list on 30 March 2022.
     IPO Open Date:  17 March 2022
     IPO Close Date:  22 March 2022
     Basis of Allotment:  25 March 2022
     Refunds:  28 March 2022
     Credit to Demat Account:  29 March 2022
     IPO Listing Date:  30 March 2022

    Evoq Remedies IPO Form

    How to apply the Evoq Remedies IPO? You can apply Evoq Remedies IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Evoq Remedies IPO in the Invest section. The other option you can apply Evoq Remedies IPO via IPO forms download via BSE website. Check out the Evoq Remedies forms - click BSE IPO Forms download, fill and submit in your bank or with your broker.

    Evoq Remedies IPO Subscription FAQs:


    When Evoq Remedies IPO Subscription will start?
    The IPO subscription starts on 17 March 2022 for NII and Retail Investors.

    How much is Evoq Remedies IPO subscribed?
    The IPO subscribed 1.67x times on day 3.

    What is Evoq Remedies IPO Retail subscription status?
    The RII subscription is 3.03x on day 3.

    How to subscribe Evoq Remedies IPO?
    You can go with ASBA and Non-ASBA options for a subscription. Go to your bank account and apply for IPO online via ASBA or download the form online or get the physical form and submit the filled form to your broker or bank.

    How do I check live Evoq Remedies IPO Subscription Numbers?
    One can visit our portal for live IPO subscription numbers that we are updating hourly basis from the official website NSE and BSE websites. One can check the live subscription on BSE or NSE website on the particular IPO page.

    Follow IPO Watch for the latest IPO news and their reviews, also keep following us on TwitterFacebook, and Instagram. For our latest videos, subscribe to our YouTube channel.